JAZZ - Jazz Pharmaceuticals PLC - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

JAZZ is currently covered by 20 analysts with an average price target of $163.37. This is a potential upside of $51.29 (45.76%) from yesterday's end of day stock price of $112.08.

Jazz Pharmaceuticals PLC's activity chart (see below) currently has 390 price targets and 349 ratings on display. The stock rating distribution of JAZZ is 90% BUY and 10% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 37.18% with an average time for these price targets to be met of 259.84 days.

Highest price target for JAZZ is $220, Lowest price target is $147, average price target is $185.44.

Most recent stock forecast was given by JEFFREY HUNG from MORGAN STANLEY on 06-Aug-2025. First documented stock forecast 31-May-2013.

Currently out of the existing stock ratings of JAZZ, 72 are a BUY (90%), 8 are a HOLD (10%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$162

$49.92 (44.54%)

$165

4 days ago
(06-Aug-2025)

1/12 (8.33%)

$56.07 (52.93%)

210

Buy

$202

$89.92 (80.23%)

$202

1 months 30 days ago
(11-Jun-2025)

3/30 (10%)

$91.5 (82.81%)

190

Buy

$147

$34.92 (31.16%)

$176

3 months 3 days ago
(07-May-2025)

10/29 (34.48%)

$45.56 (44.91%)

625

Buy

$155

$42.92 (38.29%)

$162

3 months 3 days ago
(07-May-2025)

0/4 (0%)

$53.56 (52.80%)

Buy

$172

$59.92 (53.46%)

$178

3 months 3 days ago
(07-May-2025)

0/12 (0%)

$70.56 (69.56%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is JAZZ (Jazz Pharmaceuticals PLC) average time for price targets to be met?

On average it took 259.84 days on average for the stock forecasts to be realized with a an average price target met ratio 37.18

Which analyst has the current highest performing score on JAZZ (Jazz Pharmaceuticals PLC) with a proven track record?

DAVID BUCK

Which analyst has the most public recommendations on JAZZ (Jazz Pharmaceuticals PLC)?

David Buck has 7 price targets and 12 ratings on JAZZ

Which analyst is the currently most bullish on JAZZ (Jazz Pharmaceuticals PLC)?

Annabel Samimy with highest potential upside - $117.92

Which analyst is the currently most reserved on JAZZ (Jazz Pharmaceuticals PLC)?

Irina Koffler with lowest potential downside - -$5

Jazz Pharmaceuticals PLC in the News

Why Jazz Pharmaceuticals (JAZZ) Stock Is Trading Up Today

What Happened? Shares of biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) jumped 4.8% in the afternoon session after the company received accelerated approval from the U.S. Food and Drug Administration (FDA) for Modeyso, its new treatment for a rare brain tumor. The drug, known as Modeyso, was approved as the first and only therapy for patients aged...

Jazz Pharmaceuticals Second Quarter 2025 Earnings: EPS Misses Expectations

Explore Jazz Pharmaceuticals’s Fair Values from the Community and select yours Jazz Pharmaceuticals (NASDAQ:JAZZ) Second Quarter 2025 Results Key Financial Results Revenue: US$1.05b (up 2.1% from 2Q 2024). Net loss: US$718.5m (down from US$168.6m profit in 2Q 2024). US$11.74 loss per share (down from US$2.68 profit in 2Q 2024). AI is about to change healthcare....
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?